Error loading player: No playable sources found

Player size: small large

Differentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer

Date

September 23, 2020

Speaker

Jennifer Guerriero, PhD

Dana-Farber Cancer Institute

Tracks

Targeting Myeloid Cells in Cancer Therapy II

Related Products

Thumbnail for Targeting Myeloid Cells in Cancer Therapy II

Targeting Myeloid Cells in Cancer Therapy II

Thumbnail for Mechanisms Governing Accumulation of Macrophages in Cancer

Mechanisms Governing Accumulation of Macrophages in Cancer

Thumbnail for Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression

Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression

Thumbnail for Short Talk: Antagonistic Antibodies Targeting LAIR1 Promote Inflammatory Phenotypes in Myeloid Cells and Activate Lymphocytes

Short Talk: Antagonistic Antibodies Targeting LAIR1 Promote Inflammatory Phenotypes in Myeloid Cells and Activate Lymphocytes

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.